3-(5,6,7,8-tetrahydro-naphthalen-2-yl)-but-2-enoic acid ethyl ester | 212078-30-3

• 分子结构分类: 有机化合物 - 苯丙烷和聚酮 - 肉桂酸及其衍生物
• 英文名称: 3-(5,6,7,8-tetrahydro-naphthalen-2-yl)-but-2-enoic acid ethyl ester
• 英文别名: 3-(5.6.7.8-tetrahydro-naphthyl-(2))-cis-crotonic acid ethyl ester；3-(5.6.7.8-Tetrahydro-naphthyl-(2))-cis-crotonsaeure-aethylester；ethyl (E)-3-(5,6,7,8-tetrahydro-2-naphthyl)crotonate；Ethyl (e)-3-(5,6,7,8-tetrahydro-2-naphtyl)crotonate；ethyl (E)-3-(5,6,7,8-tetrahydronaphthalen-2-yl)but-2-enoate
• CAS: 212078-30-3
• 化学式: C₁₆H₂₀O₂
• 分子量: 244.334
• InChiKey: HYUCLFRVFGKKKP-ZRDIBKRKSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  4.6
• 重原子数：
  18
• 可旋转键数：
  4
• 环数：
  2.0
• sp3杂化的碳原子比例：
  0.44
• 拓扑面积：
  26.3
• 氢给体数：
  0
• 氢受体数：
  2

反应信息

• 作为反应物：
  描述：

  3-(5,6,7,8-tetrahydro-naphthalen-2-yl)-but-2-enoic acid ethyl ester 在 二异丁基氢化铝 作用下， 以 二氯甲烷 、 甲苯 为溶剂， 生成 3-(5,6,7,8-tetrahydro-naphthalen-2-yl)-but-2-en-1-ol
  参考文献：
  名称：

  Fused ring compounds, process for producing the same and use thereof

  摘要：

  提供一种新颖的化合物，其化学式为： 其中A1是一个5或6成员环，可以被不含环状基团的基团取代，A2是一个芳香环，可以被取代，X是一个二价基团，Y是一个氮原子或一个亚甲基基团，Z是一个可以被取代的乙烯基或乙炔基，R是一个可以被取代的杂环基团，但不包括3,4-二氢-6-[3-(1H-咪唑-1-基)-1-丙烯基]-2(1H)-喹啉和2-[3-[5-乙基-6-甲基-2-(苄氧基)-3-吡啶基]-1-丙烯基]苯并噁唑，或其盐，具有类固醇C17,20-裂解酶抑制活性，对于预防和治疗患有原发性癌症、恶性肿瘤、其转移和复发等疾病的哺乳动物是有用的。

  公开号：

  US06420375B1
• 作为产物：
  描述：

  6-乙酰基-1,2,3,4-四氢萘 在 碘 、 对甲苯磺酸 、 锌 作用下， 以 苯 为溶剂， 反应 7.0h， 生成 3-(5,6,7,8-tetrahydro-naphthalen-2-yl)-but-2-enoic acid ethyl ester
  参考文献：
  名称：

  New Adamantane-Based Spiro 1,2,4-Trioxanes Orally Effective against Rodent and Simian Malaria

  摘要：

  New 6-arylvinyl- and 6-adamantylvinyl-substituted 1,2,4-trioxanes (13a-g and 14a,b) have been prepared and evaluated for antimalarial activity against multidrug resistant Plasmodium yoelii nigeriensis in mice by both oral and intramuscular routes. While all the 6-arylvinyl-substituted trioxanes, 13a-f, showed promising activity, none of the 6-adamantylvinyl-substituted trioxanes, 13g and 14a,b, exhibited significant activity. Trioxane, 13f, the most active compound of the series, provided 100% and 80% protection to malaria-infected mice at 48 mg/kg x 4 days and 24 mg/kg x 4 days, respectively, by oral route. In this model, beta-arteether (3) provided 100% protection at 48 mg/kg x 4 days and only 20% protection at 24 mg/kg x 4 days. Trioxane 13f also showed complete suppression of parasitaemia at 10 mg/kg x 4 days by oral route in rhesus monkeys infected with P. cynomolgi. None of these trioxanes, except 13f, showed significant activity by the intramuscular route.

  DOI：

  10.1021/jm0610043

文献信息

• Fused ring compounds, process for producing the same and use thereof
  申请人：Takeda Chemical Industries, Ltd.

  公开号：US06420375B1

  公开（公告）日：2002-07-16

  To provide a novel compound of the formula: [wherein A1 ix a 5 or 6-membered ring which may be substituted by a group not containing a cyclic group, A2 is an aromatic ring which may be substituted, X is a divalent group, Y is a nitrogen atom or a methine group, Z is an ethenylene which may be substituted or ethynylene, R is a heterocyclic group which may be substituted, provided that 3,4-dihydro-6-[3-(1H-imidazol-1-yl)-1-propenyl]-2(1H)-quinolone and 2-[3-[5-ethyl-6-methyl-2-(benzyloxy)-3-pyridyl]-1-propenyl]benzoxazole are excluded.], or a salt thereof which has steroid C17,20-lyase inhibitory activity, and is useful for preventing and treating mammals suffering from, for example, primary cancer of malignant tumor, its metastasis and recurrence thereof.

  提供一种新颖的化合物，其化学式为： 其中A1是一个5或6成员环，可以被不含环状基团的基团取代，A2是一个芳香环，可以被取代，X是一个二价基团，Y是一个氮原子或一个亚甲基基团，Z是一个可以被取代的乙烯基或乙炔基，R是一个可以被取代的杂环基团，但不包括3,4-二氢-6-[3-(1H-咪唑-1-基)-1-丙烯基]-2(1H)-喹啉和2-[3-[5-乙基-6-甲基-2-(苄氧基)-3-吡啶基]-1-丙烯基]苯并噁唑，或其盐，具有类固醇C17,20-裂解酶抑制活性，对于预防和治疗患有原发性癌症、恶性肿瘤、其转移和复发等疾病的哺乳动物是有用的。
• Barrera i Costa, Annales de Chimie (Cachan, France), 1949, vol. <12> 4, p. 84,123
  作者：Barrera i Costa

  DOI：——

  日期：——
• New Adamantane-Based Spiro 1,2,4-Trioxanes Orally Effective against Rodent and Simian Malaria
  作者：Chandan Singh、Rani Kanchan、Upasana Sharma、Sunil K. Puri

  DOI：10.1021/jm0610043

  日期：2007.2.8

  New 6-arylvinyl- and 6-adamantylvinyl-substituted 1,2,4-trioxanes (13a-g and 14a,b) have been prepared and evaluated for antimalarial activity against multidrug resistant Plasmodium yoelii nigeriensis in mice by both oral and intramuscular routes. While all the 6-arylvinyl-substituted trioxanes, 13a-f, showed promising activity, none of the 6-adamantylvinyl-substituted trioxanes, 13g and 14a,b, exhibited significant activity. Trioxane, 13f, the most active compound of the series, provided 100% and 80% protection to malaria-infected mice at 48 mg/kg x 4 days and 24 mg/kg x 4 days, respectively, by oral route. In this model, beta-arteether (3) provided 100% protection at 48 mg/kg x 4 days and only 20% protection at 24 mg/kg x 4 days. Trioxane 13f also showed complete suppression of parasitaemia at 10 mg/kg x 4 days by oral route in rhesus monkeys infected with P. cynomolgi. None of these trioxanes, except 13f, showed significant activity by the intramuscular route.